Literature DB >> 20229079

Adult dermatomyositis with severe polyneuropathy: does neuromyositis exist?

Makoto Nomura1, Takeshi Watanabe, Hirotsugu Mikami, Hiroaki Ishikawa, Kanako Yasui, Toshihiro Yamazaki, Togo Irie, Megumi Suzuki, Seiitsu Ono.   

Abstract

Peripheral nerve involvement in dermatomyositis (DM) has been known as neuromyositis. However, the pathogenic mechanism is not clear, and the association between DM and peripheral neuropathy is still controversial. Our patient exhibited symptomatic polyneuropathy that was documented electrophysiologically in addition to typical features of DM. The sural nerve biopsy showed evidence of a continuing neuropathic process of axonal type. There was no finding of inflammatory cells infiltrating the vessels. Neither methylprednisolone nor intravenous immunoglobulin (IVIg) improved neurological symptoms including muscle weakness and sensory disturbance. Clinical, electrophysiological, and neuropathological features in our case demonstrate the association of DM and polyneuropathy. The possibility that the same pathological process affecting skin and skeletal muscles also affected peripheral nerves in our patient should be considered.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229079     DOI: 10.1007/s10072-010-0246-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

1.  Neuromyositis.

Authors:  K D BARRON; D I FINE
Journal:  J Nerv Ment Dis       Date:  1959-06       Impact factor: 2.254

2.  NEUROMYOSITIS: A REAPPRAISAL.

Authors:  W J MCENTEE; E L MANCALL
Journal:  Neurology       Date:  1965-01       Impact factor: 9.910

Review 3.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

4.  Dermatomyositis: A study of five cases.

Authors:  T D Kinney; M M Maher
Journal:  Am J Pathol       Date:  1940-09       Impact factor: 4.307

5.  Polymyositis/dermatomyositis and polyneuropathy, or, does neuromyositis exist?

Authors:  R Laraki; O Blétry; P Godeau
Journal:  J Rheumatol       Date:  1996-12       Impact factor: 4.666

Review 6.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

7.  Dermatomyositis with peripheral nervous system involvement: activation of vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) in vasculitic lesions.

Authors:  Naoko Matsui; Takao Mitsui; Itsuro Endo; Yasushi Oshima; Makoto Kunishige; Toshio Matsumoto
Journal:  Intern Med       Date:  2003-12       Impact factor: 1.271

Review 8.  Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.

Authors:  Marinos C Dalakas
Journal:  Curr Opin Neurol       Date:  2004-10       Impact factor: 5.710

9.  Polyneuropathy in juvenile dermatomyositis.

Authors:  S A Vogelgesang; J Gutierrez; G L Klipple; I M Katona
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

  9 in total
  2 in total

1.  Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome.

Authors:  Stéphane Mathis; Laurent Magy; Philippe Corcia; Karima Ghorab; Laurence Richard; Jonathan Ciron; Mathilde Duchesne; Jean-Michel Vallat
Journal:  Case Rep Neurol Med       Date:  2016-12-01

2.  Differential and spatial expression meta-analysis of genes identified in genome-wide association studies of depression.

Authors:  Wennie Wu; Derek Howard; Etienne Sibille; Leon French
Journal:  Transl Psychiatry       Date:  2021-01-04       Impact factor: 6.222

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.